AdvaMed’s 2026 Women’s Health Webinar Series gathers members and the medtech industry to explore current opportunities in women’s health. This free series will focus on representation in clinical studies and investment in women’s health companies and products.
The series begins with Current Trends and Opportunities in Women’s Health, a high-level discussion of innovation in women’s health. Medtech leaders will highlight recent developments, emerging opportunities, and current challenges, along with ways to address them. Speakers will share insights on navigating the product development process—from design through post-market—to improve health outcomes for all women. Don’t miss candid insights on what’s working, what’s emerging, and what still needs to change.
Plus, help shape the future of the 2026 series. The series will go deeper on investment and clinical research so we welcome your questions on the topics that matter to you.
Panelists
Additional speakers to be announced soon.
Moderator: Monika McDole-Russell, MS, RAC, Sr. Director, Global Regulatory Intelligence and Advertising/Promotion, Intuitive
Monika McDole-Russell, MS, RAC, Sr. Director, Global Regulatory Intelligence and Advertising/Promotion, Intuitive
Monika McDole-Russell is a seasoned regulatory affairs executive currently serving as the Sr. Director of Global Regulatory Intelligence and Advertising/Promotion at Intuitive. With extensive global experience in Class II and III medical devices, including AI/ML technologies, Monika has successfully led regulatory strategies for over 25 products and engaged with agencies like the FDA and EU Notified Bodies. Previously, Monika held senior roles at Medtronic and DePuy Synthes, where they shaped regulatory strategies and mentored emerging professionals. In addition to their leadership in regulatory affairs, Monika is a committed advocate for gender equity in STEMM. Monika holds a Professional Certificate in Computer Science for Artificial Intelligence from Harvard University.
Regina Deible, Senior Director Clinical Affairs, Edwards Lifesciences
Regina Deible, Senior Director Clinical Affairs, Edwards Lifesciences
Regina Deible has over 40 years of cardiovascular experience with more than 180 publications, abstracts and presentations. Both national and international experience as a director, speaker and/or moderator for CV educational programs (such as CRT, TCT, VIVA, EuroPCR and NCVH).
Julia Grapsa, M.D., Heart and Vascular Institute, Mass General Brigham, Harvard Medical School
Julia Grapsa, Heart and Vascular Institute, Mass General Brigham, Harvard Medical School
Dr Julia Grapsa is an associate physician, specialized in valvular heart disease and echocardiography. She is the Director for Education in echocardiography at Brigham and Women’s Hospital and faculty staff for Harvard Medical School. Prior to this position, she served as an attending cardiologist at Guy’s and St Thomas’ NHS Foundation Trustin London since March 2020. She led the imaging team for tricuspid services. Prior to that position, she was director for non-invasive cardiology at Royal London Hospital. She has been an attending cardiologist since 2013.
Tracy MacNeal, President and CEO, Materna Medical
Tracy MacNeal, President and CEO, Materna Medical
Tracy MacNeal is a healthcare executive with a specialty in commercializing medical devices. With 6 successful transactions and over 20 years in pharmaceuticals, digital health, and women’s health, she brings a wealth of experience to the medtech industry. A deep believer in collaboration within our shared healthcare ecosystem, Tracy serves on the Board of Directors for AdvaMed as well as on the AdvaMed Accel Board of Directors. Tracy is President and CEO of Materna Medical, a novel OBGYN platform company that defines a $25B market in the most common pelvic conditions women face.
Tracy holds a BE in Chemical Engineering from The Cooper Union and graduated summa cum laude with an MBA from Duke University’s Fuqua School of Business.
Hear From Us
Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.